The Mexican consensus on the treatment of hepatitis C

Rev Gastroenterol Mex (Engl Ed). 2018 Jul-Sep;83(3):275-324. doi: 10.1016/j.rgmx.2017.11.001. Epub 2018 May 24.
[Article in English, Spanish]

Abstract

The aim of the Mexican Consensus on the Treatment of HepatitisC was to develop clinical practice guidelines applicable to Mexico. The expert opinion of specialists in the following areas was taken into account: gastroenterology, infectious diseases, and hepatology. A search of the medical literature was carried out on the MEDLINE, EMBASE, and CENTRAL databases through keywords related to hepatitisC treatment. The quality of evidence was subsequently evaluated using the GRADE system and the consensus statements were formulated. The statements were then voted upon, using the modified Delphi system, and reviewed and corrected by a panel of 34 voting participants. Finally, the level of agreement was classified for each statement. The present guidelines provide recommendations with an emphasis on the new direct-acting antivirals, to facilitate their use in clinical practice. Each case must be individualized according to the comorbidities involved and patient management must always be multidisciplinary.

Keywords: Agentes antivirales de acción directa; Consenso; Consensus; Direct-acting antiviral agents; Interferon-free regimens; Regímenes libres de interferón; Ribavirin; Ribavirina.

Publication types

  • Practice Guideline

MeSH terms

  • Antiviral Agents / therapeutic use
  • Consensus
  • Evidence-Based Medicine
  • Hepatitis C / drug therapy
  • Hepatitis C / therapy*
  • Humans
  • Mexico

Substances

  • Antiviral Agents